XKRX
036180
Market cap20mUSD
Aug 19, Last price
489.00KRW
Name
GW Vitek Co Ltd
Chart & performance
P/E
—
P/S
1.63
EPS
—
Vol. 1Y
—
Shs. 5Y
39.48%
Rev. 5Y
-8.83%
Div Yld LY
—
Div Yld TTM
—
Revenues
28.07b
-41.42%
Net income
-12.25b
L-17.94%
CFO
-2.87b
L-72.78%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Based in South Korea, GW Vitek Co Ltd operates within the scientific and technical instrumentation field. The enterprise manufactures a diverse range of products, including apparatus for life sciences and industrial processes, biological reagents, essential laboratory tools, and imaging devices. Furthermore, it provides metabolic analysis services.
Key people
Gang Gil Jang
Internal Auditor
Yeo Hwan Ahn
Chief Executive Officer, Director · since 2012
Seok Cheol Bae
Director · since 2019
Jong Wung Baek
Director · since 2010
Seok Hwan Choi
Director
Ji Wung Hyun
Director · since 2019
Chief Executive Officer, Director · since 2020
Min Choel Kim
Director · since 2019
Hyeok Jin Gwon
Non-Executive Independent Director · since 2019
Hui Suk Son
Non-Executive Independent Director · since 2019
Valuation
Title KRW in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||